forecast ep middl guidanc rang due cost
benefit buy-back underli ep estim vs
guidanc support ebit benefit
final year ann transform program modest raw materi tailwind
share buy-back plu full-year benefit share
count follow buy-back execut
offset fx tax headwind weak organ revenu growth
review activ trend suggest subdu revenu
growth recent pmi data suggest continu deterior ip growth
across key developed/develop region ann key us distributor
note weak demand flat market volum forecast ann miss
cc organ sale growth target cc growth
compris growth healthcar growth industri sale
forecast signific recoveri demand ann
success price negoti custom last month
enabl continu see improv organ revenu growth
forecast particularli cycl easier comp
larg enough warrant downgrad given ann
numer cost benefit support earn estim ann could
still reach bottom end guidanc even cc organ sale growth
view think highli unlik eventu due
stabl strong growth healthcar gbu less influenc
weak ip growth stronger price outcom see risk ann
guid toward lower end guidanc think unlik
manag would lower bottom-end guidanc rang
retain neutral rate tp make minor chang
estim reduc earn view risk current
balanc stock trade earn ann strong
balanc sheet net debt/ebitda cost-out
off-set challeng oper environ
valuat metric
chang previou ep
price month
total return forecast perspect
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
price book
return equiti
return asset
return invest cap
net debt ebitda
capital-expenditure sale
capital-expenditure depr
profit tax
profit tax
unusu item tax
chang work capit
cash non-cash item
movement cash/equival
 asx close
spot exchang rate
bridg ep guidanc
ann guid underli ep forecast
underli ep middl manag guidanc rang bridg
ep estim shown figur
manag like updat market guidanc rang
novemb see risk ann guid toward lower end guidanc think
unlik manag would lower bottom-end guidanc rang key
view assumpt vs manag guidanc consider provid
result detail
organ sale growth return organ growth rang mani initi
cs view given sign improv macro condit europ
continu soft us forecast ann continu miss organ sale
growth forecast forecast organ sale growth cc
result weaker industri volum despit posit price outcom
cycl easier comp continu strength healthcar sale
growth forecast organ sale growth cc
cost continu ebit growth transform program price lower raw
materi cost better product mix
cs view forecast transform benefit given lower
raw materi price forecast ebit benefit
expect ep accret ringer acquisit
minim disrupt potenti new tariff and/or brexit implic
tax rate higher effect tax rate rang unfavour
cs view forecast effect tax rate vs
fx unfavour fx
cs view fx movement continu unfavour sinc
factor fx headwind
 buy-back deploy excess cash buy-back support ep
higher end guidanc rang
cs view continu buy-back program place forecast ann buying-
back share
ann bought back share
ep bridg estim
sensit analysi organ sale growth requir meet top/bottom
end guidanc
given ann numer
material/transform benefit share buy-back
one area uncertainti
surround ann earn level organ sale growth outlin
scenario organ sale growth would lead ann achiev top bottom
end manag guidanc leav assumpt equal
bottom end guidanc ep us impli cc organ sale growth
top end guidanc ep us impli cc organ sale growth
despit weak demand industri divis ann posit
healthcar gbu particular single-us market remain strong given ann wide
guidanc rang sensit analysi perform view think
highli unlik manag either upgrade/downgrad guidanc rang
rather think like like guidanc rang tighten
risk lie downsid
lower ep
review key activ trend made minor chang
assumpt result ep downgrad adjust includ
updat currenc assumpt base credit suiss in-hous forecast
updat assumpt buy-back given faster rate complet vs
decreas raw materi cost growth due eas price seen
decreas organ growth assumpt industri divis given continu
weak macro trend
retain neutral rate tp
retain neutral rate make chang dcf-deriv target
price stock trade forward consensu earn line
two year averag earn growth view share
fairli valu
figur pe line long-term averag
figur discount market
ann pe rel industri ex financi
chart bloomberg profession servic credit suiss estim
gener pmi trend mix across ann key market sinc begin
europ contract continu deepen us despit fear contract
continu experi expansionari activ data develop countri show
improv expansionari trend brazil china yet continu weak
contract russia figur note recent pmi data weight ann
geograph exposur impli expect reduct level ip growth
figur contractionari pmi data
market pmi varianc
figur peak
chart bloomberg profession servic credit suiss estim
implic ann
ann revenu exposur emea ann
miss organ growth target achiev cc growth
particular saw cc declin organ sale industri gbu impact emea
deceler north america slowdown pmi data end
suggest signific improv
histor organ growth ann industri gbu follow weight ip growth
key region figur ip growth explain variat organ
revenu growth figur howev recent year seen correl
industri revenu weight ip growth break symptomat
intern issu affect growth
weight basi revenu contribut pmi data indic weaker
activ given pmi data histor provid reason lead indic
industri product ip growth note reason yet precis relationship
ann industri focus gbu ip recent trend highlight scope slower
industri organ growth
figur explain varianc growth
chart compani data bloomberg profession servic credit suiss estim
also monitor trend daili sale growth data grainger
wholesal industri suppli north america ann featur within product
rang distributor report moder growth
grainger record daili sale growth msc industri fall
outperform peer septemb quarter growth slow
player daili sale growth moder high singl digit-to-doubl
market commentari rel consist amongst distributor
grainger global demand environ continu weaken expect market
rel flattish
industri industri demand deterior quarter progress
fasten pmi signal fairli flattish volum
figur core end market
chart compani data credit suiss estim
ann achiev organ sale growth target
organ growth industri growth healthcar given seen
signific improv industri market condit see downsid risk ann
achiev target rang
forecast ann miss target achiev cc organ sale growth
cc growth growth come healthcar divis
growth industri divis demand volum like remain weak
posit price negoti custom last month enabl
continu see revenu growth particularli cycl easier comp
figur lower industri sale
ann organ revenu growth divis
chart compani data credit suiss estim
raw materi price continu modest benefit
raw materi account ann cog ann largest raw
materi categori fibr engin yarn combin nitril
natur rubber raw materi repres raw materi mix
figur raw materi cog
chart compani data credit suiss estim
key input nitril includ butadien acrylonitril monitor recent
price movement butadien price vs pcp
averag butadien price remain rel flat vs acrylonitril
price lower vs pcp declin averag sinc
cotton polyamid fibr price also eas yoy respect
figur raw materi price
figur benefit earn
chart bloomberg profession servic credit suiss estim
figur materi chang butadien
figur acrylonitril price eas
chart bloomberg profession servic credit suiss estim
chart bloomberg profession servic credit suiss estim
estim mn ebit benefit
raw materi price continu eas particularli cotton fibr price given
month lag price impact cog continu
benefit cost increas ebit benefit mn
fx headwind
revenu currenc eur depreci rel usd neg
usd translat figur movement key cost currenc myr thb
account total cost mix figur
ann hedg fx exposur roll basi
unfavour usdeur movement would like still neg impact earn
ann guid ep headwind believ greater given
recent currenc move sinc guidanc given factor headwind
figur neg revenu fx chang septq figur mix cost currenc movement
chart bloomberg profession servic credit suiss estim
figur healthcar revenu
figur industri ebit
figur cog opex
figur ebit step
figur ep grow
figur dp
chart compani data credit suiss estim
new total return forecast perspect chart help visual credit suiss consensu view compani return within
context forecast risk histor trade pattern
volatil calcul annualis standard deviat weekli total return seri past month illustr variabl
stock return word risk way think one would rather take forecast return stock volatil
stock volatil shade area show one standard deviat rang base past month volatil statist
term make number brave assumpt probabl share price end insid rang month
hi-lo maximum minimum daili close price past week often handi know price momentum especi
stock trade close high low stock trade close peak momentum stock
consensu consensu suppli thomson reuter survey sell side research analyst collect dozen data
point ep dp sale target price roe mean averag target return shade area around mean
repres rang estim lowest highest estim aid visualis number import factor rang
analyst estim credit suiss estim stock sit rel consensu share price rel consensu
mean consensu rang target
return calcul capit gain plu forecast dividend yield net next month cs tgt use credit suiss
target price credit suiss forecast forward dividend gross frank consensu mean rang use
consensu target price consensu dividend forecast month forward
compani mention price
